In vitro fertilization/intracytoplasmic sperm injection for male infertility

Area of Science:

• Reproductive Medicine
• Genetics
• Assisted Reproductive Technology

Background:

• Severe male factor infertility, previously untreatable, can now be managed with assisted reproduction.
• Micromanipulation techniques like intracytoplasmic sperm injection (ICSI) overcome natural conception barriers.

Purpose of the Study:

• To review the indications, advantages, limitations, outcomes, and safety of using in vitro fertilization with ICSI for male factor infertility.
• To promote judicious use of these techniques and minimize complications.

Main Methods:

• Review of literature on ICSI for male factor infertility.
• Analysis of outcomes including fertilization, pregnancy, and ongoing pregnancy rates.
• Discussion of genetic implications and safety concerns.

Main Results:

• ICSI can be performed with various sperm sources (ejaculate, epididymal, testicular) yielding satisfactory results.
• Despite success, there are concerns regarding genetic implications and transmission of disorders.
• Lack of consensus exists on preimplantation genetic diagnosis efficacy.

Conclusions:

• ICSI provides a viable option for severe male infertility, including azoospermia.
• Thorough genetic evaluation and counseling are essential before ICSI procedures.
• Further research is needed on the long-term safety and genetic implications of ICSI.